What is the association between cancer and thrombosis? Why should we care?
What are the principles of thromboprophylaxis in oncology patients? (Guidelines and recommendations)
What are the main clinical features of coagulopathy in COVID-19 disease?
Is the cumulative thrombotic risk like a “perfect thrombotic storm” in oncology patients during COVID-19 pandemic?
Making clinical decisions regarding CAT management taking into consideration the potential cumulative thrombotic risk in COVID-19 era. Should oncologists modify their clinical practice?